Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

Neurology - 28 Aug 2012

Hu William T, Holtzman David M, Fagan Anne M, Shaw Leslie M, Perrin Richard, Arnold Steven E, Grossman Murray, Xiong Chengjie, Craig-Schapiro Rebecca, Clark Christopher M, Pickering Eve, Kuhn Max, Chen Yu, Van Deerlin Vivianna M, McCluskey Leo, Elman Lauren, Karlawish Jason, Chen-Plotkin Alice, Hurtig Howard I, Siderowf Andrew, Swenson Frank, Lee Virginia M-Y, Morris John C, Trojanowski John Q, Soares Holly

Abstract excerpt

OBJECTIVES: While plasma biomarkers have been proposed to aid in the clinical diagnosis of Alzheimer disease (AD), few biomarkers have been validated in independent patient cohorts. Here we aim to determine plasma biomarkers associated with AD in 2 independent cohorts and validate the findings in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analysis of Variance
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Chemical Analysis

Share to Cognitive Dysfunction

Share to Data Interpretation, Statistical

Share to Linear Models

Share to Longitudinal Studies

Share to Neuropsychological Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 22855860
DOI: 10.1212/WNL.0b013e318266fa70
PMCID: PMC3425844

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22855860-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.PMID 22855860Read ↗

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortSemantic proximity Read ↗

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s diseaseSemantic proximity Read ↗

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in DementiaSemantic proximity Read ↗

Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity Read ↗

Identification of Novel Biomarkers for Alzheimer’s Disease and Related Dementias Using Unbiased Plasma ProteomicsSemantic proximity Read ↗

Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s diseaseSemantic proximity Read ↗

Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.Semantic proximity Read ↗

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.Semantic proximity Read ↗

Plasma proteomic signatures predict dementia and cognitive impairmentSemantic proximity Read ↗

Plasma biomarkers for mild cognitive impairment and Alzheimer's diseaseSemantic proximity Read ↗

Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.